A CFSE based assay for measuring CD4+CD25+ regulatory T cell mediated suppression of auto-antigen specific and polyclonal T cell responses

Journal of Immunological Methods

Volumn 322, Issue 1-2, 2007, Pages 1-11

  Venken, Koen ^a   Thewissen, Marielle ^a   Hellings, Niels ^a   Somers, Veerle ^a   Hensen, Karen ^b   Rummens, Jean Luc ^b   Stinissen, Piet ^a  

^a HASSELT UNIVERSITY   (Belgium)

^b VIRGA JESSE HOSPITAL   (Belgium)

Author keywords

CD4+CD25+ regulatory T cells; CFSE; Myelin responses

Indexed keywords

5,6 CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; 7 AMINODACTINOMYCIN; ACTINOMYCIN DERIVATIVE; AUTOANTIGEN; CD4 ANTIGEN; FLUORESCEIN DIACETATE; GAMMA INTERFERON; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; MYELIN BASIC PROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; TETANUS TOXOID; UNCLASSIFIED DRUG;

ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CD4+ CD25+ T LYMPHOCYTE; CELL PROLIFERATION; CLONAL ANERGY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNE RESPONSE; MALE; MULTIPLE SCLEROSIS; NORMAL HUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SUPPRESSOR CELL;

EID: 34147092225     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2007.01.025     Document Type: Article

References (38)

1. Baecher-Allan C., Brown J.A., Freeman G.J., and Hafler D.A. CD4+CD25high regulatory cells in human peripheral blood. J. Immunol. 167 (2001) 1245
2. Baecher-Allan C., Viglietta V., and Hafler D.A. Inhibition of human CD4(+)CD25(+high) regulatory T cell function. J. Immunol. 169 (2002) 6210
3. Balandina A., Lecart S., Dartevelle P., Saoudi A., and Berrih-Aknin S. Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis. Blood 105 (2005) 735
4. Birebent B., Lorho R., Lechartier H., de Guibert S., Alizadeh M., Vu N., Beauplet A., Robillard N., and Semana G. Suppressive properties of human CD4+CD25+ regulatory T cells are dependent on CTLA-4 expression. Eur. J. Immunol. 34 (2004) 3485
5. Camara N.O., Sebille F., and Lechler R.I. Human CD4+CD25+ regulatory cells have marked and sustained effects on CD8+ T cell activation. Eur. J. Immunol. 33 (2003) 3473
6. Crawford M.P., Yan S.X., Ortega S.B., Mehta R.S., Hewitt R.E., Price D.A., Stastny P., Douek D.C., Koup R.A., Racke M.K., and Karandikar N.J. High prevalence of autoreactive, neuroantigen specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay. Blood 103 (2004) 4222
7. Deibler G.E., Martenson R.E., and Kies M.W. Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species. Prep. Biochem. 2 (1972) 139
8. Fisson S., Darrasse-Jeze G., Litvinova E., Septier F., Klatzmann D., Liblau R., and Salomon B.L. Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state. J. Exp. Med. 198 (2003) 737
9. Fontenot J.D., Gavin M.A., and Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4 (2003) 330
10. Gondek D.C., Lu L.F., Quezada S.A., Sakaguchi S., and Noelle R.J. Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J. Immunol. 174 (2005) 1783
11. Grossman W.J., Verbsky J.W., Barchet W., Colonna M., Atkinson J.P., and Ley T.J. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 21 (2004) 589
12. Haas J., Hug A., Viehover A., Fritzsching B., Falk C.S., Filser A., Vetter T., Milkova L., Korporal M., Fritz B., Storch-Hagenlocher B., Krammer P.H., Suri-Payer E., and Wildemann B. Reduced suppressive effect of CD4(+)CD25(high) regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis. Eur. J. Immunol. 35 (2005) 3343
13. Hellings N., Baree M., Verhoeven C., D'hooghe M.B., Medaer R., Bernard C.C., Raus J., and Stinissen P. T cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls. J. Neurosci. Res. 63 (2001) 290
14. Hellings N., Raus J., and Stinissen P. Insights into the immunopathogenesis of multiple sclerosis. Immunol. Res. 25 (2002) 27
15. Hermans G., Stinissen P., Hauben L., Berg-Loonen E., Raus J., and Zhang J. Cytokine profile of myelin basic protein-reactive T cells in multiple sclerosis and healthy individuals. Ann. Neurol. 42 (1997) 18
16. Hori S., Nomura T., and Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299 (2003) 1057
17. Hsieh C.S., Liang Y., Tyznik A.J., Self S.G., Liggitt D., and Rudensky A.Y. Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors. Immunity 21 (2004) 267
18. Huan J., Culbertson N., Spencer L., Bartholomew R., Burrows G.G., Chou Y.K., Bourdette D., Ziegler S.F., Offner H., and Vandenbark A.A. Decreased FOXP3 levels in multiple sclerosis patients. J. Neurosci. Res. 81 (2005) 45
19. Khattri R., Cox T., Yasayko S.A., and Ramsdell F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol. 4 (2003) 337
20. Lim H.W., Hillsamer P., Banham A.H., and Kim C.H. Cutting edge: direct suppression of B cells by CD4+ CD25+ regulatory T cells. J. Immunol. 175 (2005) 4180
21. Lyons A.B. Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. J. Immunol. Methods 243 (2000) 147
22. Lyons A.B., and Parish C.R. Determination of lymphocyte division by flow cytometry. J. Immunol. Methods 171 (1994) 131
23. Mannering S.I., Morris J.S., Jensen K.P., Purcell A.W., Honeyman M.C., van Endert P.M., and Harrison L.C. A sensitive method for detecting proliferation of rare auto-antigen specific human T cells. J. Immunol. Methods 283 (2003) 173
24. Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6 (2005) 345
25. Shevach E.M., McHugh R.S., Piccirillo C.A., and Thornton A.M. Control of T cell activation by CD4+ CD25+ suppressor T cells. Immunol. Rev. 182 (2001) 58
26. Shimizu J., Yamazaki S., Takahashi T., Ishida Y., and Sakaguchi S. Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol. 3 (2002) 135
27. Taams L.S., Smith J., Rustin M.H., Salmon M., Poulter L.W., and Akbar A.N. Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population. Eur. J. Immunol. 31 (2001) 1122
28. Taams L.S., Vukmanovic-Stejic M., Smith J., Dunne P.J., Fletcher J.M., Plunkett F.J., Ebeling S.B., Lombardi G., Rustin M.H., Bijlsma J.W., Lafeber F.P., Salmon M., and Akbar A.N. Antigen-specific T cell suppression by human CD4+CD25+ regulatory T cells. Eur. J. Immunol. 32 (2002) 1621
29. Taams L.S., van Amelsfort J.M., Tiemessen M.M., Jacobs K.M., de Jong E.C., Akbar A.N., Bijlsma J.W., and Lafeber F.P. Modulation of monocyte/macrophage function by human CD4+CD25+ regulatory T cells. Hum. Immunol. 66 (2005) 222
30. Takahashi T., Tagami T., Yamazaki S., Uede T., Shimizu J., Sakaguchi N., Mak T.W., and Sakaguchi S. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192 (2000) 303
31. Van der Aa A., Hellings N., Bernard C.C., Raus J., and Stinissen P. Functional properties of myelin oligodendrocyte glycoprotein-reactive T cells in multiple sclerosis patients and controls. J. Neuroimmunol. 137 (2003) 164
32. Venken K., Hellings N., Hensen K., Rummens J.L., Medaer R., D'hooghe M.B., Dubois B., Raus J., and Stinissen P. Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4(+)CD25(+) regulatory T cell function and FOXP3 expression. J. Neurosci. Res. 83 (2006) 1432
33. Viglietta V., Baecher-Allan C., Weiner H.L., and Hafler D.A. Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis. J. Exp. Med. 199 (2004) 971
34. Von Boehmer H. Mechanisms of suppression by suppressor T cells. Nat. Immunol. 6 (2005) 338
35. Walker L.S., Chodos A., Eggena M., Dooms H., and Abbas A.K. Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo. J. Exp. Med. 198 (2003) 249
36. Walker M.R., Carson B.D., Nepom G.T., Ziegler S.F., and Buckner J.H. De novo generation of antigen specific CD4+CD25+ regulatory T cells from human CD4+. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 4103
37. Wing K., Lindgren S., Kollberg G., Lundgren A., Harris R.A., Rudin A., Lundin S., and Suri-Payer E. CD4 T cell activation by myelin oligodendrocyte glycoprotein is suppressed by adult but not cord blood CD25+ T cells. Eur. J. Immunol. 33 (2003) 579
38. Zelenay S., Lopes-Carvalho T., Caramalho I., Moraes-Fontes M.F., Rebelo M., and Demengeot J. Foxp3+ CD25- CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 4091